TITLE

Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis

AUTHOR(S)
Isenberg, David A.; Karassa, Fontini B.
PUB. DATE
February 2001
SOURCE
New England Journal of Medicine;02/01/2001, Vol. 344 Issue 5, p382
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to an article by Tak Mao Chan about the efficacy of the drug mycophenolate mofetil in patients with diffuse proliferative lupus nephritis which appeared in the October 19, 2000 issue.
ACCESSION #
24902386

 

Related Articles

  • Comment on the WASPO study. Channer, Kevin; Rash, Amar; Downes, Tort // Age & Ageing;Sep2007, Vol. 36 Issue 5, p599 

    A response by Kevin Channer, Amar rash and Tom Downes to a letter to the editor about the efficacy and tolerability of warfarin or aspirin as thromboprophylaxis in octogenarians is presented.

  • High-Dose Intravenous Immune Globulin for Stiff-Person Syndrome. Sudo, Kazumasa; Tajima, Yasutaka; Matsumoto, Akihisa // New England Journal of Medicine;5/30/2002, Vol. 346 Issue 22, p1747 

    A letter to the editor is presented in response to an article about the efficacy of high-dose intravenous immune globulin for the treatment of stiff-person syndrome in the December 27, 2001 issue.

  • High-Dose Intravenous Immune Globulin for Stiff-Person Syndrome. Solaro, Claudio // New England Journal of Medicine;5/30/2002, Vol. 346 Issue 22, p1747 

    A letter to the editor is presented in response to an article about the efficacy of high-dose intravenous immune globulin for the treatment of stiff-person syndrome in the December 27, 2001 issue.

  • High-Dose Intravenous Immune Globulin for Stiff-Person Syndrome. Dalakas, Marinos C. // New England Journal of Medicine;5/30/2002, Vol. 346 Issue 22, p1747 

    A response by Marinos C. Dalakas to a letter to the editor about an article on the efficacy of high-dose intravenous immune globulin for the treatment of stiff-person syndrome in the December 27, 2001 issue is presented.

  • Thiazolidinediones. Davidson, Mayer B. // New England Journal of Medicine;1/13/2005, Vol. 352 Issue 2, p205 

    A letter to the editor about an article by H. Yki-J�rvinen on the benefits of thiazolidinediones drugs in the September 9, 2004 issue is presented.

  • Thiazolidinediones. Edelman, Steven V. // New England Journal of Medicine;1/13/2005, Vol. 352 Issue 2, p205 

    A letter to the editor about an article by H. Yki-J�rvinen on the benefits of thiazolidinediones drugs in the September 9, 2004 issue is presented.

  • Thiazolidinediones. Mascitelli, Luca; Pezzetta, Francesca // New England Journal of Medicine;1/13/2005, Vol. 352 Issue 2, p205 

    A letter to the editor about an article by H. Yki-J�rvinen on the benefits of thiazolidinediones drugs in the September 9, 2004 issue is presented.

  • Thiazolidinediones. Yki-Järvinen, Hannele // New England Journal of Medicine;1/13/2005, Vol. 352 Issue 2, p205 

    A response by Hannele Yki-J�rvinen to several letters to the editor on her article on the benefits of thiazolidinediones drugs in the September 9, 2004 issue is presented.

  • Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis. Chan, Tak Mao // New England Journal of Medicine;02/01/2001, Vol. 344 Issue 5, p382 

    A response by Tak Mao Chan to a letter the editor in response to their article about the efficacy of the drug mycophenolate mofetil in patients with diffuse proliferative lupus nephritis, which appeared in the October 19, 2000 issue, is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics